A1BNI: methyl (2S)-2-({(2S)-2-[(2R,3S)-3-{[(2S,4R,5R,6R)-4-{[(2S,4R,5S,6R)-4-{[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-7-{[(2S,4R,5R,6R)-4-{[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-5,10-dihydroxy-6-methyl-4-oxo-1,2,3,4-tetrahydroanthracen-2-yl]-2-methoxyacetyl}amino)-3-(5-methyl-1H-indol-3-yl)propanoate (non-preferred name)
A1BNI is a Ligand Of Interest in 9MOZ designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9MOZ_A1BNI_A_103 | 87% | 40% | 0.059 | 0.978 | 0.95 | 1.28 | 4 | 20 | 0 | 0 | 100% | 1 |
| 9MOZ_A1BNI_A_104 | 85% | 42% | 0.063 | 0.979 | 0.95 | 1.2 | 4 | 13 | 0 | 0 | 100% | 1 |
| 9MOZ_A1BNI_G_105 | 84% | 45% | 0.065 | 0.978 | 0.92 | 1.13 | 2 | 12 | 0 | 0 | 100% | 1 |
| 9MOZ_A1BNI_D_103 | 84% | 42% | 0.062 | 0.972 | 0.94 | 1.22 | 4 | 14 | 0 | 0 | 100% | 1 |
| 9MOZ_A1BNI_G_103 | 80% | 43% | 0.069 | 0.968 | 0.95 | 1.16 | 4 | 13 | 0 | 0 | 100% | 1 |
| 9MOZ_A1BNI_D_104 | 79% | 47% | 0.073 | 0.972 | 0.91 | 1.06 | 3 | 11 | 0 | 0 | 100% | 1 |
